Skip to main content
SpringerLink
Log in

Retinoid Receptors in Human Breast Carcinoma: Possible Modulators of in Situ Estrogen Metabolism

  • Conference Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Retinoid receptors (retinoic acid (RARs) and retinoid X (RXRs) receptors) were immunolocalized in 32 human invasive ductal breast carcinomas. These findings were correlated with clinicopathological parameters to study their biological significance in breast carcinoma. Retinoid receptor immunoreactivity, except for RXRγ, was detected in the nuclei of carcinoma cells. Percentage of positive cases were RARα 81%, RARβ; 6%, RARγ; 28%, RXRα; 81%, and RXRβ; 59%. A significant correlation was detected between RARα labeling index (LI), and RXRα LI (r=0.667, p<0.001). Results from immunoblotting performed in three cases were consistent with those of immunohistochemistry. There was a significant correlation between RARα LI and 17β-hydroxysteroid dehydrogenase (17β-HSD) type 1 immunoreactivity (p<0.05). A significant correlation was also detected between RARα (r=0.413, p=0.019) or RXRα (r=0.429, p=0.014) LI, and estrogen receptor (ER) LI. In T-47D breast cancer cells, which express RARα, RXRα and ER, 17β-HSD reductive activity increased 1.76-fold (p<0.001), five days following treatment with 10nM retinoic acid. These data suggest that retinoid receptors modulate various effects of retinoids, including estrogen metabolism in human breast carcinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sporn MB, Dunlop NM, Newton DL, Smith JM: Prevention of chemical carcinogenesis by vitam in A and its synthetic analogs (retinoids). Fed Proc 35: 1332-1338, 1976

    Google Scholar 

  2. Peto R, Doll R, Buckley JD, Sporn MB: Can dietary β-carotine materially reduce human cancer rates? Nature (Lond) 290: 201-208, 1981

    Google Scholar 

  3. Lipman SM, Kessler JF, Meyskens FL Jr.: Retinoids as preventive and therapeutic anticancer agents (Part 1). Cancer Treat Res 71: 391-405, 1987

    Google Scholar 

  4. Petkovich M, Brand NJ, Krust A, Chambon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330: 444-450, 1987

    Google Scholar 

  5. Giguere V, Ong ES, Sequi P, Evans R: Identification of a receptor for the morphogen retinoic acid. Nature 330: 624-629, 1987

    Google Scholar 

  6. de The H, Marchio A, Tiollais P, Dejean A: A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma. Nature 330: 667-670, 1987

    Google Scholar 

  7. Brand N, Petkovich M, Krust A, Chambon P, de The H, Marchio A, Tillais P, Dejean A: Identification of a second human retinoic acid receptor. Nature 332: 850-853, 1988

    Google Scholar 

  8. Krust A, Kastner P, Petkovich M, Zelent A, Chambon P: A third human retinoic acid receptor hRARγ. Proc Natl Acad Sci USA 86: 5310-5314, 1989

    Google Scholar 

  9. Hamada K, Gleason SL, Levi B-Z, Hirschfed S, Appella E, Ozato K: H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen responsive element. Proc Natl Acad Sci USA 86: 8289-8293, 1989

    Google Scholar 

  10. Mangelsdorf DJ, Ong ES, Dyck JA, Evancs RM: Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345: 224-229, 1990

    Google Scholar 

  11. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM: Characterization of three RXR genes that mediate the action of 9-cis-retinoic acid. Genes Dev 6: 329-344, 1992

    Google Scholar 

  12. Leid M, Kastner P, Chambon P: Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci 17: 427-433, 1992

    Google Scholar 

  13. Chambon P: A decade of molecular biology of retinoic acid receptors. FASEB J 10: 940-954, 1996

    Google Scholar 

  14. Marth C, Mayer I, Daxenbichler G: Effect of retinoic acid and 4-hydroxytamoxifen on human breast cancer cell lines. Biochem Pharmacol 33: 2217-2221, 1984

    Google Scholar 

  15. Fontana JA, Miranda D, Mezu AB: Retinoic acid inhibition of human breast carcinoma proliferation is accompanied by inhibition of the synthesis of a M 39, 000 protein. Cancer Res 50: 1977-1982, 1990

    Google Scholar 

  16. van der Brug B, van der Leede BM, Kwakkenboslsbrucker L, Salverda S, de Laat SW, van der Saag PT: Retinoic acid resistance of estradiol-independent breast cancer cell lines coincidence with diminished expression of functional retinoic acid receptors. Mol Cell Endocrinol 91: 149-157, 1993

    Google Scholar 

  17. Roman SD, Ormandy CJ, Manning DL, Blamey RW, Nicholson RI, Sutherland RL, Clarke CL: Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res 53: 5940-5945, 1993

    Google Scholar 

  18. van der Leede BM, Geertzema J, Vroom TM, Decimo D, Lutz Y, van der Saag PT, van der Brug B: Immunohistochemical analysis of retinoic acid receptor-a in human breast tumors. Am J Pathol 148: 1905-1914, 1996

    Google Scholar 

  19. Widschwendter M, Berger J, Daxenbichler G, Muller-Holzner E, Widschwendter A, Mayr A, Marth C, Zeimet AG: Loss of retinoic acid receptor α expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res 57: 4158-4161, 1997

    Google Scholar 

  20. Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K, Lotan R: Progressive decrease in nuclear retinoic acid receptor b messenger RNA level during breast carcinogenesis. Cancer Res 57: 4992-4996, 1997

    Google Scholar 

  21. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377, 1957

    Google Scholar 

  22. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer. Experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991

    Google Scholar 

  23. Sugawara A, Yen PM, Qi Y, Lechan RM, Chin WW: Isoformspecific retinoid-X receptor (RXR) antibodies detect differential expression of RXR proteins in the pituitary gland. Endocrinology 136: 1766-1774, 1995

    Google Scholar 

  24. Sanno N, Sugawara A, Teramoto A, Abe Y, Yen PM, Clin WW, Osamura RY: Immunohistochemical expression of retinoid X receptor isoforms in human pituitaries and pituitary adenomas. Neuroendocrinology 65: 299-306, 1996

    Google Scholar 

  25. Poutanen M, Isomaa V, Lehto VP, Vihko R: Immunohistochemical analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue. Int J Cancer 50: 386-390, 1992

    Google Scholar 

  26. Suzuki T, Sasano H, Kimura N, Tamura M, Fukaya T, Yajima A, Nagura H: Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes. Hum Reprod 9: 1589-1595, 1994

    Google Scholar 

  27. Suzuki T, Sasano H, Takaya R, Fukaya T, Yajima A, Nagura H: Cyclic changes of vasculature and vascular phenotypes in normal human ovaries. Hum Reprod 13: 953-959, 1998

    Google Scholar 

  28. Suzuki T, Moriya T, Ariga N, Kaneko C, Kanazawa M, Sasano H: 17b-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters. Brit J Canc 82: 524-528, 2000

    Google Scholar 

  29. Takayama K, Sasano H, Fukaya T, Morohashi K-I, Suzuki T, Tamura M, Costa MJ, Yajima A: Immunohistochemical localization of Ad4-binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors. J Clin Endocrinol Metab 80: 2815-2821, 1995

    Google Scholar 

  30. Lowry OH, Rosebrough NJ, Farr LA, Randall RJ: Protein measurements with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951

    Google Scholar 

  31. Nagata T, Kanno Y, Ozato K, Taketo M: The mouse Rxrb gene encoding RXRβ: genomic organization and two mRNA isoforms generated by alternative splicing of transcripts initiated from CpG island promoters. Gene 142: 183-189, 1994

    Google Scholar 

  32. Lawrence JA, Merino MJ, Simpson JF, Manrow RE, P age DL, Steeg PS: A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor. Cancer Epidemioly, Biomarkers and Prevention 7: 29-35, 1998

    Google Scholar 

  33. Siddiqui NA, Thomas EJ, Dunlop W, Redfern CP: Retinoic acid receptors and retinoid binding proteins in endometrial adenocarcinoma: differential expression of cellular retinoid binding proteins in endometrioid tumours. Int J Cancer 64: 253-263, 1995

    Google Scholar 

  34. Picard E, Seguin C, Monhoven N, Rochette-Egly C, Siat J, Borrelly J, Martinet Y, Martinet N, Vignaud JM: Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J Natl Cancer Inst 91: 1059-1066, 1999

    Google Scholar 

  35. Katsetos CD, Stadnicka I, Boyd JC, Ehya H, Zheng S, Soprano CM, Cooper HS, Patchefsky AS, Soprano DR, Soprano KJ: Cellular distribution of retinoic acid receptor-alpha protein in serous adenocarcinomas of ovarian, tubal, and peritoneal origin: comparison with estrogen receptor status. Am J Pathol 153: 469-480, 1998

    Google Scholar 

  36. Sheikh MS, Shao Z, Li X, Dawson M, Jetten AM, Wu S, Conley BA, Garcia M, rochefort H, Fontana JA: Retinoid resistant estrogen receptor negative human breast carcinoma cells transfected with retinoic acid receptor a acquire sensitivity to growth inhibition by retinoids. J Biol Chem 269: 21440-21447, 1994

    Google Scholar 

  37. Fitzgerald P, Teng M, Chandraratna RAS, Heyman RA, Allegretto EA: Retinoic acid receptor a expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Cancer Res 57: 2642-2650, 1997

    Google Scholar 

  38. Roman SD, Clarke CL, Hall RE, Alexander IE, Sutherland RL: Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res 52: 2236-2242, 1992

    Google Scholar 

  39. Peltoketo H, Isomaa V, Maentausta O, Vihko R: Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett 239: 73-77, 1988

    Google Scholar 

  40. Luu-The V, Labrie C, Zhao HF, Couet J, Lachance Y, Simard J, Leblanc G, Cote J, Berube D, Gagne R, Labrie F: Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 50-termini in human placenta. Mol Endocrinol 3: 1301-1309, 1989

    Google Scholar 

  41. Gast MJ, Sims HF, Murdock GL, Gast PM, Strauss AW: Isolation and sequencing of a cDNA clone encoding human placental 17β-estradiol dehydrogenase: identification of the putative cofactor binding site. Am J Obstet Gynecol 161: 1726-1731, 1989

    Google Scholar 

  42. Wu L, Einstein M, Geissler WM, Chan HK, Ellison KO, Andersson S: Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J Biol Chem 168: 12964-12969, 1993

    Google Scholar 

  43. Sasano H, Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R, Bulun SE, Silverberg SG, Nagura H: Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metab 81: 4042-4046, 1996

    Google Scholar 

  44. Reed MJ, Rea D, Duncan LJ, Parker MG: Regulation of estradiol 17β-hydroxysteroid dehydrogenase expression and activity by retinoic acid in T47D breast cancer cells. Endocrinology 135: 4-9, 1994

    Google Scholar 

  45. Wouters W, Dun VD, Dillen A, Coene M-C, Cools W, De Coster R: Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells. Cancer Res 52: 2841-2846, 1992

    Google Scholar 

  46. Veronese SM, Gambacorta M, Gottardi O, Scanzi F, Ferrari M, Lampertico P: Proliferation index as a prognostic marker in breast cancer. Cancer 71: 3926-3931, 1993

    Google Scholar 

  47. Cassidy J, Lippman M, Lacroix A, Peck G: Phase II trial of 13-cis-retinoic acid in metastatic breast cancer. Eur J Cancer Clin Oncol 18: 925-928, 1982

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Tohoku University School of Medicine, Sendai, Japan

    Takashi Suzuki, Hiroaki Takabayashi & Hironobu Sasano

  2. Department of Pathology, Tohoku University Hospital, Sendai, japan

    Takuya Moriya, Naohira Ariga & Hironobu Sasano

  3. 2nd Department of Internal Medicine, Tohoku University School of Medicine, S, endai, Japan

    Akira Sugawara

Authors
  1. Takashi Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takuya Moriya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akira Sugawara
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naohira Ariga
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroaki Takabayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hironobu Sasano
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, T., Moriya, T., Sugawara, A. et al. Retinoid Receptors in Human Breast Carcinoma: Possible Modulators of in Situ Estrogen Metabolism. Breast Cancer Res Treat 65, 31–40 (2001). https://doi.org/10.1023/A:1006433929792

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006433929792

Search

Navigation